当前位置:首页 - 行情中心 - 甘李药业(603087) - 财务分析

甘李药业

(603087)

  

流通市值:372.65亿  总市值:399.00亿
流通股本:5.58亿   总股本:5.97亿

甘李药业(603087)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润8.18亿元,每股收益1.38元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1128239.25万元,未分配利润697986.27万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1214275.77万元,负债86036.52万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,047,039,079.242,066,795,642.77984,867,402.613,045,347,805.11
营业总成本2,275,937,092.071,515,608,273.35739,374,819.172,663,266,844.19
其他经营收益
营业利润868,653,239.12631,605,004.11299,042,200.26631,540,152.08
利润总额925,710,035.08691,021,014.97360,390,884.31630,385,148.09
净利润818,339,617.3603,680,572.48311,918,723.02614,663,800.7
每股收益
其他综合收益-406,764.76-21,049.12338,986.22219,526.81
综合收益总额817,932,852.54603,659,523.36312,257,709.24614,883,327.51
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计4,968,496,815.273,966,168,927.343,900,272,940.753,790,858,209.05
非流动资产:
非流动资产合计7,174,260,871.697,911,626,582.458,384,161,878.048,252,058,182.83
资产总计12,142,757,686.9611,877,795,509.7912,284,434,818.7912,042,916,391.88
流动负债:
流动负债合计690,456,931.84735,070,490.35793,214,596.86801,131,734.24
非流动负债:
非流动负债合计169,908,284.09177,494,307.38179,096,772.33187,313,995.46
负债合计860,365,215.93912,564,797.73972,311,369.19988,445,729.7
所有者权益(或股东权益):
归属于母公司股东权益合计11,282,392,471.0310,965,230,712.0611,312,123,449.611,054,470,662.18
股东权益合计11,282,392,471.0310,965,230,712.0611,312,123,449.611,054,470,662.18
负债和股东权益合计12,142,757,686.9611,877,795,509.7912,284,434,818.7912,042,916,391.88
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,960,577,867.951,959,456,149.261,016,722,117.213,388,272,777.65
经营活动现金流出小计2,478,617,411.381,710,905,907.17857,975,850.442,850,963,054.35
经营活动产生的现金流量净额481,960,456.57248,550,242.09158,746,266.77537,309,723.3
投资活动产生的现金流量:
投资活动现金流入小计4,942,143,757.753,156,092,918.682,058,063,660.248,857,807,746.37
投资活动现金流出小计4,610,620,481.382,626,039,316.12,030,819,263.169,119,836,143.8
投资活动产生的现金流量净额331,523,276.37530,053,602.5827,244,397.08-262,028,397.43
筹资活动产生的现金流量:
筹资活动现金流入小计---139,321,600
筹资活动现金流出小计737,269,148.6733,344,416.0775,214,479.7440,035,383
筹资活动产生的现金流量净额-737,269,148.6-733,344,416.07-75,214,479.7-300,713,783
汇率变动对现金及现金等价物的影响2,686,658.893,302,350.071,466,877.94-951,386.7
现金及现金等价物净增加额78,901,243.2348,561,778.67112,243,062.09-26,383,843.83
期末现金及现金等价物余额338,956,379.99308,616,915.43372,298,198.85260,055,136.76
补充资料:
现金及现金等价物的净增加额-48,561,778.67--26,383,843.83
最新报告期:2025-09-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋李啸岩,谭紫媚1.922.473.072025-09-11
中信证券陈竹,韩世通1.912.413.022025-08-20
兴业证券孙媛媛,黄翰漾1.932.412.872025-08-15
华安证券谭国超1.852.372.972025-08-13
东方证券伍云飞,赵博宇1.912.402.842025-08-12
TOP↑